Nashville Expansion Announced by Harrow
Tennessee Governor Bill Lee, along with Economic and Community Development Commissioner Stuart C. McWhorter and Harrow, Inc. CEO Mark L. Baum, announced today that Harrow is expanding its corporate headquarters…
Fujirebio Files FDA Submission for Alzheimer’s Plasma Diagnostic Test
Fujirebio has announced that its subsidiary, Fujirebio Diagnostics, Inc., has submitted the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test to the U.S. Food and Drug Administration…
Omnicell Names Nnamdi Njoku as Executive Vice President and Chief Operating Officer
Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming pharmacy care delivery, has announced the appointment of Nnamdi Njoku as Executive Vice President and Chief Operating Officer, effective October 7, 2024.…
Medidata Strengthens Focus on Patient Experience with Launch of Patient Payments
Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has introduced Medidata Patient Payments, a new solution designed to simplify the process…
Takeda Gets Approval for FRUZAQLA in Japan for Advanced Colorectal Cancer
Takeda (TSE:4502/NYSE) has announced that the Japanese Ministry of Health, Labour and Welfare has approved the manufacture and marketing of FRUZAQLA Capsules (1mg/5mg), containing fruquintinib, a selective oral inhibitor targeting…
Rituxan Approved for Steroid-Resistant Nephrotic Syndrome
Zenyaku Kogyo Co., Ltd. (Japanese-only website) and Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) have announced that Zenyaku has received regulatory approval from the Ministry of Health, Labour and Welfare (MHLW)…
Roche Unveils First Test with TAGS Tech for Detecting 12 Respiratory Viruses
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced the launch of its new cobas® Respiratory flex test, the first to incorporate Roche’s proprietary TAGS (Temperature-Activated Generation of Signal) technology. This…
Empowering Women Entrepreneurs 2024 BOTOX Cosmetic Grant Launches Crowdfunding
Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), proudly announces the next chapter of its 2024 BOTOX® Cosmetic grant program, focused on empowering women entrepreneurs. This phase introduces crowdfunding campaigns…
Lilly’s Kisunla (donanemab-azbt) Receives Approval in Japan for Treating Early Symptomatic Alzheimer’s Disease
The Ministry of Health, Labour and Welfare of Japan has approved Kisunla™ (donanemab-azbt, 350 mg/20 mL injection for IV infusion every four weeks), Eli Lilly and Company’s (NYSE: LLY) treatment…
Arrowhead Pharmaceuticals Seeks Clearance for Phase 1/2a Study of ARO-INHBE in Obesity Treatment
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has announced that it has filed for regulatory approval to launch a Phase 1/2a clinical trial for ARO-INHBE, its investigational RNA interference (RNAi) therapeutic aimed…
ImpriMed Launches AI Cancer Treatment Prediction at EHA-SfPM, Expands Precision Medicine to Humans
a leading precision medicine company utilizing artificial intelligence (AI) to enhance cancer treatment, has announced its expansion into human oncology. Building on its successful work in veterinary oncology, ImpriMed will…
Lantern Pharma Receives FDA Rare Pediatric Disease Designations for LP-184 in Ultra-Rare Children’s Cancers
Lantern Pharma Inc. (NASDAQ: LTRN), an AI-driven biotech company focused on developing targeted cancer therapies through its proprietary RADR® AI and machine learning platform, announced that the FDA has granted…